Integral Diagnostics Management
Management criteria checks 2/4
Integral Diagnostics' CEO is Ian Kadish, appointed in May 2017, has a tenure of 8.42 years. total yearly compensation is A$1.46M, comprised of 54.4% salary and 45.6% bonuses, including company stock and options. directly owns 0.17% of the company’s shares, worth $1.08M. The average tenure of the management team and the board of directors is 0.8 years and 2.1 years respectively.
Key information
Ian Kadish
Chief executive officer
AU$1.5m
Total compensation
| CEO salary percentage | 54.40% |
| CEO tenure | 8.4yrs |
| CEO ownership | 0.2% |
| Management average tenure | less than a year |
| Board average tenure | 2.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2025 | AU$1m | AU$794k | AU$5m |
| Mar 31 2025 | n/a | n/a | AU$5m |
| Dec 31 2024 | n/a | n/a | AU$6m |
| Sep 30 2024 | n/a | n/a | -AU$28m |
| Jun 30 2024 | AU$1m | AU$825k | -AU$61m |
| Mar 31 2024 | n/a | n/a | -AU$59m |
| Dec 31 2023 | n/a | n/a | -AU$58m |
| Sep 30 2023 | n/a | n/a | -AU$16m |
| Jun 30 2023 | AU$1m | AU$794k | AU$25m |
| Mar 31 2023 | n/a | n/a | AU$23m |
| Dec 31 2022 | n/a | n/a | AU$21m |
| Sep 30 2022 | n/a | n/a | AU$18m |
| Jun 30 2022 | n/a | AU$781k | AU$15m |
| Mar 31 2022 | n/a | n/a | AU$18m |
| Dec 31 2021 | n/a | n/a | AU$22m |
| Sep 30 2021 | n/a | n/a | AU$26m |
| Jun 30 2021 | AU$2m | AU$736k | AU$31m |
| Mar 31 2021 | n/a | n/a | AU$32m |
| Dec 31 2020 | n/a | n/a | AU$32m |
| Sep 30 2020 | n/a | n/a | AU$28m |
| Jun 30 2020 | AU$1m | AU$635k | AU$23m |
| Mar 31 2020 | n/a | n/a | AU$22m |
| Dec 31 2019 | n/a | n/a | AU$21m |
| Sep 30 2019 | n/a | n/a | AU$21m |
| Jun 30 2019 | AU$876k | AU$549k | AU$21m |
Compensation vs Market: Ian's total compensation ($USD947.60K) is below average for companies of similar size in the US market ($USD3.48M).
Compensation vs Earnings: Ian's compensation has been consistent with company performance over the past year.
CEO
Ian Kadish (62 yo)
Dr. Ian Kadish, MBBCh, MBA, serves as the Chief Executive Officer, Managing Director and a Director at Capitol Health Limited since December 11, 2024. He has been the Chief Executive Officer, Managing Dire...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD & Executive Director | 8.4yrs | AU$1.46m | 0.17% $ 1.1m | |
| Radiologist Executive Director | less than a year | AU$837.89k | 0.57% $ 3.6m | |
| Chief Financial Officer | 1.7yrs | no data | no data | |
| Chief Information Officer | 6.1yrs | no data | no data | |
| Chief People Officer | less than a year | no data | no data | |
| Chief Integration Officer | less than a year | no data | no data | |
| Co-Chief Medical Officer | less than a year | no data | no data | |
| Co-Chief Medical Officer | less than a year | no data | no data | |
| Company Secretary | 1.3yrs | no data | no data |
Experienced Management: ITGD.F's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD & Executive Director | no data | AU$1.46m | 0.17% $ 1.1m | |
| Radiologist Executive Director | less than a year | AU$837.89k | 0.57% $ 3.6m | |
| Independent Non-Executive Director | 8yrs | AU$150.00k | 0.012% $ 77.2k | |
| Independent Non-Executive Director | 3.3yrs | AU$137.50k | 0.023% $ 142.9k | |
| Independent Non-Executive Director | 2.2yrs | AU$150.00k | 0.0094% $ 58.8k | |
| Independent Non-Executive Chairman | 2.1yrs | AU$250.46k | 0.052% $ 326.6k | |
| Independent Non-Executive Director | less than a year | AU$63.47k | 0.0040% $ 24.8k | |
| Independent Non-Executive Director | less than a year | AU$63.47k | no data |
Experienced Board: ITGD.F's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/22 00:31 |
| End of Day Share Price | 2025/09/05 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Integral Diagnostics Limited is covered by 21 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Benjamin Brayshaw | Barrenjoey Markets Pty Limited |
| Thomas Yeo | Barrenjoey Markets Pty Limited |
| Saul Hadassin | Barrenjoey Markets Pty Limited |